MRKR – Marker Therapeutics Inc
Marker Therapeutics, Inc.MRKR
$1.35Name : Marker Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $15,389,055.00
EPSttm : -1.32
Marker Therapeutics, Inc.
$1.35
3.57%$0.05Float Short %
1.3
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.14
EPS Last/This Y
EPS This/Next Y
0.51
Price
1.35
Target Price
6
Analyst Recom
1
Performance Q
13.42
Relative Volume
0.2
Beta
1.45
Ticker: MRKR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-07 | MRKR | 1.562 | N/A | N/A | 0 |
| 2025-07-08 | MRKR | 1.6 | N/A | N/A | 0 |
| 2025-07-09 | MRKR | 1.82 | N/A | N/A | 0 |
| 2025-07-10 | MRKR | 1.81 | N/A | N/A | 0 |
| 2025-07-11 | MRKR | 1.705 | N/A | N/A | 0 |
| 2025-07-14 | MRKR | 1.57 | N/A | N/A | 0 |
| 2025-07-15 | MRKR | 1.57 | N/A | N/A | 0 |
| 2025-07-16 | MRKR | 1.6 | N/A | N/A | 0 |
| 2025-07-17 | MRKR | 1.925 | N/A | N/A | 0 |
| 2025-07-18 | MRKR | 1.67 | N/A | N/A | 0 |
| 2025-07-21 | MRKR | 1.54 | N/A | N/A | 0 |
| 2025-07-22 | MRKR | 1.618 | N/A | N/A | 0 |
| 2025-07-23 | MRKR | 1.58 | N/A | N/A | 0 |
| 2025-07-24 | MRKR | 1.51 | N/A | N/A | 0 |
| 2025-07-25 | MRKR | 1.56 | N/A | N/A | 0 |
| 2025-07-28 | MRKR | 1.5576 | N/A | N/A | 0 |
| 2025-07-29 | MRKR | 1.42 | N/A | N/A | 0 |
| 2025-07-30 | MRKR | 1.38 | N/A | N/A | 0 |
| 2025-07-31 | MRKR | 1.41 | N/A | N/A | 0 |
| 2025-08-01 | MRKR | 1.36 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-07 | MRKR | 1.57 | -8.0 | - | -1.19 |
| 2025-07-08 | MRKR | 1.60 | -8.0 | - | -1.19 |
| 2025-07-09 | MRKR | 1.81 | -8.0 | - | -1.19 |
| 2025-07-10 | MRKR | 1.80 | -8.0 | - | -1.19 |
| 2025-07-11 | MRKR | 1.71 | -8.0 | - | -1.19 |
| 2025-07-14 | MRKR | 1.58 | -8.0 | - | -1.19 |
| 2025-07-15 | MRKR | 1.57 | -8.0 | - | -1.19 |
| 2025-07-16 | MRKR | 1.60 | -8.0 | - | -1.19 |
| 2025-07-17 | MRKR | 1.92 | -8.0 | - | -1.19 |
| 2025-07-18 | MRKR | 1.67 | -8.0 | - | -1.19 |
| 2025-07-21 | MRKR | 1.55 | -8.0 | - | -1.19 |
| 2025-07-22 | MRKR | 1.60 | -8.0 | - | -1.19 |
| 2025-07-23 | MRKR | 1.60 | -8.0 | - | -1.19 |
| 2025-07-24 | MRKR | 1.50 | -8.0 | - | -1.19 |
| 2025-07-25 | MRKR | 1.56 | -8.0 | - | -1.19 |
| 2025-07-28 | MRKR | 1.52 | -8.0 | - | -1.19 |
| 2025-07-29 | MRKR | 1.41 | -8.0 | - | -1.19 |
| 2025-07-30 | MRKR | 1.38 | -8.0 | - | -1.19 |
| 2025-07-31 | MRKR | 1.40 | -8.0 | - | -1.19 |
| 2025-08-01 | MRKR | 1.35 | -8.0 | - | -1.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-07 | MRKR | 0.00 | -13.58 | 2.19 |
| 2025-07-08 | MRKR | 0.00 | -13.58 | 2.19 |
| 2025-07-09 | MRKR | 0.00 | -13.58 | 2.19 |
| 2025-07-10 | MRKR | 0.00 | -13.58 | 2.19 |
| 2025-07-11 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-14 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-15 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-16 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-17 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-18 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-21 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-22 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-23 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-24 | MRKR | 0.00 | -13.58 | 1.55 |
| 2025-07-25 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-28 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-29 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-30 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-07-31 | MRKR | 0.00 | -13.58 | 1.30 |
| 2025-08-01 | MRKR | 0.00 | -13.58 | 1.30 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.4
Avg. EPS Est. Current Quarter
-0.27
Avg. EPS Est. Next Quarter
-0.26
Insider Transactions
Institutional Transactions
-13.58
Beta
1.45
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
28
Sentiment Score
24
Actual DrawDown %
96.4
Max Drawdown 5-Year %
-98
Target Price
6
P/E
Forward P/E
PEG
P/S
2.68
P/B
1.04
P/Free Cash Flow
EPS
-1.33
Average EPS Est. Cur. Y
-1.19
EPS Next Y. (Est.)
-0.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-224.45
Relative Volume
0.2
Return on Equity vs Sector %
-112
Return on Equity vs Industry %
-93.3
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading